mepolizumab
gsk
['mepolizumab']
i typically do not use mepolizumab for "vasculitic" egpa --&gt; recent acr/vf guidelines agreed interesting study suggests benefit regardless of anca, bvas, vdi have others been using in this context or seen similar? #acr22 #acrbest #1075 
MCW Rheumatologist | Internal Medicine APD | Rheumatology APD | Med Dir Vasculitis Program | Host, EBRheum Podcast | https://t.co/o4nOnziCiM | Newsletter: